Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$2.69B+10.9%$2.59B+6.4%$2.52B+3.6%$2.45B-1.0%$2.43B+0.7%
$553M+5.9%$543M+3.0%$534M-0.2%$527M-2.8%$522M-4.6%
-$29M+5.7%-$30M+38.1%-$21M+67.8%
$237M+13.4%$220M-6.4%$186M-27.3%$192M-28.9%$209M-25.1%
-$242M-164%-$232M-167%$44M-78.5%$442M+135%$381M+129%
-$0.50-164%-$0.47-167%$0.09-78.0%$0.90+135%$0.78+129%
2B+0.6%2B+0.4%2B+0.7%2B+1.0%2B+0.7%
-$29M+5.7%-$30M+38.1%-$21M+67.8%
$244M+116%$237M+58.0%$42M-76.5%$34M-80.9%$113M-15.0%
$731M$676M
$40M-$4M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Elanco Animal Health Inc.'s revenue?
Elanco Animal Health Inc. (ELAN) generated $4.9B in revenue over the trailing twelve months, up 10.5% year over year.
Is Elanco Animal Health Inc. profitable?
Elanco Animal Health Inc. is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months, a -4.9% net margin.
What is Elanco Animal Health Inc.'s earnings per share?
Elanco Animal Health Inc.'s diluted EPS over the trailing twelve months is $-0.50.
Where does Elanco Animal Health Inc.'s income statement data come from?
Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.